Lefitolimod (TLR agonist) and ipilimumab in patients with advanced solid tumors: A phase I trial

被引:0
|
作者
Nardo, Mirella
Reilley, Matthew
Biter, Amadeo
Lim, Joann
Bean, Stacie A.
Nguyen, Ly Minh
Bhosale, Priya
Ager, Casey
Couillault, Coline A.
Piha-Paul, Sarina A.
Fu, Siqing
Tsimberidou, Apostolia Maria
Yap, Timothy A.
Naing, Aung
Ahnert, Jordi Rodon
Subbiah, Vivek
Karp, Daniel D.
Curran, Michael A.
Hong, David S.
机构
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[2] Univ Virginia, Charlottesville, VA USA
[3] Columbia Univ, Med Ctr, New York, NY USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Houston, TX USA
基金
美国国家卫生研究院;
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2564
引用
收藏
页数:1
相关论文
共 50 条
  • [41] A phase I trial of MK-2206 and hydroxychloroquine in patients with advanced solid tumors
    Janice M. Mehnert
    Amanda D. Kaveney
    Jyoti Malhotra
    Kristen Spencer
    Daniella Portal
    Susan Goodin
    Antoinette R. Tan
    Joseph Aisner
    Rebecca A. Moss
    Hongxia Lin
    Joseph R. Bertino
    Darlene Gibbon
    Laurence A. Doyle
    Eileen P. White
    Mark N. Stein
    Cancer Chemotherapy and Pharmacology, 2019, 84 : 899 - 907
  • [42] A phase I trial of the combination of erlotinib and tipifarnib in patients with advanced solid tumors.
    Ma, CX
    Croghan, G
    Reid, J
    Hanson, L
    Mandrekar, S
    Marks, R
    Adjei, A
    Furth, A
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 192S - 192S
  • [43] Phase I targeted combination trial of sorafenib and erlotinib in patients with advanced solid tumors
    Duran, Ignacio
    Hotte, Sebastien J.
    Hirte, Holger
    Chen, Eric X.
    MacLean, Martha
    Turner, Sandra
    Duan, Lixia
    Pond, Gregory R.
    Lathia, Chetan
    Walsh, Scott
    Wright, John J.
    Dancey, Janet
    Siu, Lillian L.
    CLINICAL CANCER RESEARCH, 2007, 13 (16) : 4849 - 4857
  • [44] Extended linifanib therapy in patients with advanced solid tumors in a phase I trial.
    Goh, B. C.
    Wong, C.
    Qian, J.
    McKeegan, E.
    Ricker, J. L.
    Carlson, D. M.
    Soo, R. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [45] Phase I clinical trial of bortezomib in combination with gemcitabine in patients with advanced solid tumors
    Ryan, David P.
    Appleman, Leonard J.
    Lynch, Thomas
    Supko, Jeffrey G.
    Fidias, Panagiotis
    Clark, Jeffrey W.
    Fishman, Mayer
    Zhu, Andrew X.
    Enzinger, Peter C.
    Kashala, Oscar
    Cusack, James, Jr.
    Eder, Joseph P.
    CANCER, 2006, 107 (10) : 2482 - 2489
  • [46] Phase I trial of gemcitabine, doxorubicin and cisplatin (GAP) in patients with advanced solid tumors
    Duran, I
    Siu, LL
    Chen, EX
    Oza, AM
    Sturgeon, J
    Chin, SF
    Brown, S
    Pond, GR
    Nottage, M
    ANTI-CANCER DRUGS, 2006, 17 (01) : 81 - 87
  • [47] Gemcitabine and Docetaxel in patients with advanced solid tumors. A GETICS phase I trial
    Jaremtchuk, AV
    Zabra, JJ
    Ferro, A
    Aman, EF
    Alvarez, R
    Arroyo, G
    Marmissolle, F
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S290 - S290
  • [48] Phase I trial of coramsine (SBP002) in patients with advanced solid tumors
    Millward, M
    Powell, A
    Tyson, S
    Daly, P
    Ferguson, R
    Carter, S
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 218S - 218S
  • [49] A clinical phase I trial of topotecan in combination with carboplatin in patients with advanced solid tumors
    Thodtmann, R
    Kemmerich, M
    Depenbrock, H
    Heuser, A
    van Oosterom, AT
    Hanauske, AR
    ANNALS OF ONCOLOGY, 1998, 9 : 69 - 69
  • [50] Phase I clinical trial of combination imatinib and ipilimumab in patients with advanced malignancies
    Reilley, Matthew
    Bailey, Ann Marie
    Subbiah, Vivek
    Janku, Filip
    Naing, Aung
    Falchook, Gerald Steven
    Karp, Daniel D.
    Piha-Paul, Sarina Anne
    Tsimberidou, Apostolia Maria
    Fu, Siqing
    Zinner, Ralph
    Lim, JoAnn
    Bean, Stacie A.
    Bass, Allison
    Montez, Sandra
    Vence, Luis M.
    Sharma, Padmanee
    Allison, James Patrick
    Meric-Bernstam, Funda
    Hong, David S.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)